Over expression of hypoxia-inducible factor-1α in renal and bladder cancer cells increases tumorigenic potency

Journal of Urology

Volumn 173, Issue 5, 2005, Pages 1762-1766

  Kondo, Yukihiro ^a   Hamada, Junko ^b   Kobayashi, Chie ^b   Nakamura, Ryosuke ^b   Suzuki, Yasutomo ^a   Kimata, Ryoji ^a   Nishimura, Taiji ^a   Kitagawa, Takayuki ^c   Kunimoto, Manabu ^b   Imura, Nobumasa ^b   Hara, Shuntaro ^b  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b KITASATO UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Angiogenesis; Bladder; HIF 1 ; Hypoxia; Kidney; Proliferation

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BLADDER CANCER; CANCER CELL; CARCINOGENICITY; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; EXPRESSION VECTOR; GENETIC TRANSFECTION; GROWTH CURVE; HISTOPATHOLOGY; HYPOXIA; KIDNEY CANCER; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR XENOGRAFT;

EID: 20244370054     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000154343.35444.09     Document Type: Article

References (20)

1. Harris, A. L.: Hypoxia - a key regulatory factor in tumour growth. Nat Rev Cancer, 2: 38, 2002
2. Semenza, G. L.: Targeting HIF-1 for cancer therapy. Nat Rev Cancer, 3: 721, 2003
3. Jones, A., Fujiyama, C., Blanche, C., Moore, J. W., Fuggle, S., Cranston, D. et al: Relation of vascular endothelial growth factor production to expression and regulation of hypoxia-inducible factor-1 alpha and hypoxia-inducible factor-2 alpha in human bladder tumors and cell lines. Clin Cancer Res, 7: 1263, 2001
4. Turner, K. J., Moore, J. W., Jones, A., Taylor, C. F., Cuthbert-Heavens, D., Han, C. et al: Expression of hypoxia-inducible factors in human renal cancer: relationship to angiogenesis and to the von Hippel-Lindau gene mutation. Cancer Res, 62: 2957, 2002
5. Carmeliet, P., Dor, Y., Herbert, J. M., Fukumura, D., Brusselmans, K., Dewerchin, M. et al: Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature, 394: 485, 1998
6. Ryan, H. E., Lo, J. and Johnson, R. S.: HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J, 17: 3005, 1998
7. Ryan, H. E., Poloni, M., McNulty, W., Elson, D., Gassmann, M., Arbeit, J. M. et al: Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth. Cancer Res, 60: 4010, 2000
8. Hopfl, G., Wenger, R. H., Ziegler, I., Stallmach, T., Gardelle, O., Achermann, R. et al: Rescue of hypoxia-inducible factor-1alpha-deficient tumor growth by wild-type cells is independent of vascular endothelial growth factor. Cancer Res, 62: 2962, 2002
9. Hara, S., Hamada, J., Kobayashi, C., Kondo, Y. and Imura, N.: Expression and characterization of hypoxia-inducible factor (HIF)-3alpha in human kidney: suppression of HIF-mediated gene expression by HIF-3alpha. Biochem Biophys Res Commun, 287: 808, 2001
10. Suzuki, T., Iwazaki, A., Katagiri, H., Oka, Y., Redpath, J. L., Stanbridge, E. J. et al: Enhanced expression of glucose transporter GLUT3 in tumorigenic HeLa cell hybrids associated with tumor suppressor dysfunction. Eur J Biochem, 262: 534, 1999
11. Weidner, N., Semple, J. P., Welch, W. R. and Folkman, J.: Tumor anigogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med, 324: 1, 1991
12. Iyer, N. V., Kotch, L. E., Agani, F., Leung, S. W., Laughner, E., Wenger, R. H. et al: Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev, 12: 149, 1998
13. Krieg, M., Haas, R., Brauch, H., Acker, T., Flamme, I. and Plate, K. H.: Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function. Oncogene, 19: 5435, 2000
14. Zhong, H., Chiles, K., Feldser, D., Laughner, E., Hanrahan, C., Georgescu, M.-M. et al: Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res, 60: 1041, 2000
15. Zundel, W., Schindler, C., Haas-Kogan, D., Koong, A., Kaper, F., Chen, E. et al: Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev, 14: 391, 2000
16. Laughner, E., Taghavi, P., Chiles, K., Mahon, P. C. and Semenza, G. L.: HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol Cell Biol, 21: 3995, 2001
17. Fukuda, R., Kelly, B. and Semenza, G. L.: Vascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E2 is mediated by hypoxia-inducible factor 1. Cancer Res, 63: 2330, 2003
18. Akakura, N., Kobayashi, M., Horuchi, I., Suzuki, A., Wang, J., Chen, J. et al: Constitutive expression of hypoxia-inducible factor-1alpha rendered pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation. Cancer Res, 61: 6548, 2001
19. Niizeki, H., Kobayashi, M., Horuichi, I., Akakura, N., Chen, J., Wang, J., Hamada, J.-I. et al: Hypoxia enhances the expression of autocrine motility factor and the motility of human pancreatic cancer cells. Br J Cancer, 86: 1914, 2002
20. Rung, A. L., Wang, S., Klco, J M., Kaelin, W. G., Jr. and Livingston, D. M.: Suppression of tumor growth through disruption of hypoxia-inducible transcription. Nat Med, 6: 1335, 2000